Definium Therapeutics, Inc. (MNMD)
NASDAQ · Healthcare
Definium Therapeutics, Inc. Total Liabilities 2020–2025
Definium Therapeutics, Inc. annual total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Definium Therapeutics, Inc. total liabilities as of December 31, 2025: 107.8M, a 77.54% increase year-over-year.
- Definium Therapeutics, Inc. total liabilities for 2025 were 107.8M, a 77.54% increase from 2024.
- Definium Therapeutics, Inc. total liabilities for 2024 were 60.7M, a 30.81% increase from 2023.
- Definium Therapeutics, Inc. total liabilities for 2023 were 46.4M, a 143.27% increase from 2022.
- Definium Therapeutics, Inc. total liabilities for 2022 were 19.1M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Definium Therapeutics, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $108 |
| 2024 | $61 |
| 2023 | $46 |
| 2022 | $19 |
| 2021 | $12 |
| 2020 | $6 |
Definium Therapeutics, Inc. Total Liabilities — FAQ
Definium Therapeutics, Inc. (MNMD) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MNMD's total liabilities history?
The chart and table above show Definium Therapeutics, Inc.'s total liabilities by year and by quarter, including the growth rate.